YAP-independent mechanotransduction drives breast cancer progression

被引:0
|
作者
Joanna Y. Lee
Jessica K. Chang
Antonia A. Dominguez
Hong-pyo Lee
Sungmin Nam
Julie Chang
Sushama Varma
Lei S. Qi
Robert B. West
Ovijit Chaudhuri
机构
[1] Stanford University,Department of Mechanical Engineering
[2] Department of Genetics,Department of Bioengineering
[3] Stanford University School of Medicine,Department of Chemical and Systems Biology
[4] Stanford University,Stanford ChEM
[5] Stanford University,H
[6] Stanford University,Department of Pathology
[7] Stanford University School of Medicine,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Increased tissue stiffness is a driver of breast cancer progression. The transcriptional regulator YAP is considered a universal mechanotransducer, based largely on 2D culture studies. However, the role of YAP during in vivo breast cancer remains unclear. Here, we find that mechanotransduction occurs independently of YAP in breast cancer patient samples and mechanically tunable 3D cultures. Mechanistically, the lack of YAP activity in 3D culture and in vivo is associated with the absence of stress fibers and an order of magnitude decrease in nuclear cross-sectional area relative to 2D culture. This work highlights the context-dependent role of YAP in mechanotransduction, and establishes that YAP does not mediate mechanotransduction in breast cancer.
引用
收藏
相关论文
共 50 条
  • [21] Erythropoietin drives breast cancer progression by activation of its receptor EPOR
    Chan, Ka Kui
    Matchett, Kyle B.
    Coulter, Jonathan A.
    Yuen, Hiu-Fung
    McCrudden, Cian M.
    Zhang, Shu-Dong
    Irwin, Gareth W.
    Davidson, Matthew A.
    Ruelicke, Thomas
    Schober, Sophie
    Hengst, Ludger
    Jaekel, Heidelinde
    Platt-Higgins, Angela
    Rudland, Philip S.
    Mills, Ken I.
    Maxwell, Perry
    El-Tanani, Mohamed
    Lappin, Terence R.
    ONCOTARGET, 2017, 8 (24): : 38251 - 38263
  • [22] MI drives progression of breast cancer by promoting a protumoural immune landscape
    Huynh, Karina
    NATURE REVIEWS CARDIOLOGY, 2020, 17 (10) : 611 - 611
  • [24] DNA hypomethylation in breast cancer: An independent parameter of tumor progression?
    Bernardino, T
    Roux, C
    Almeida, A
    Vogt, N
    Gibaud, A
    GerbaultSeureau, M
    Magdelenat, H
    Bourgeois, CA
    Malfoy, B
    Dutrillaux, B
    CANCER GENETICS AND CYTOGENETICS, 1997, 97 (02) : 83 - 89
  • [25] The Hippo-YAP/TAZ pathway mediates geranylgeranylation signaling in breast cancer progression
    Lin, Qiong
    Yang, Wannian
    MOLECULAR & CELLULAR ONCOLOGY, 2016, 3 (03)
  • [26] Iron-Bound Lipocalin-2 from Tumor-Associated Macrophages Drives Breast Cancer Progression Independent of Ferroportin
    Mertens, Christina
    Schnetz, Matthias
    Rehwald, Claudia
    Grein, Stephan
    Elwakeel, Eiman
    Weigert, Andreas
    Bruene, Bernhard
    Jung, Michaela
    METABOLITES, 2021, 11 (03)
  • [27] A pro-metastatic alternative splicing program that drives breast cancer progression
    Goodarzi, Hani
    Fish, Lisa
    Culbertson, Bruce
    CANCER RESEARCH, 2020, 80 (04)
  • [28] YAP Dictates Mitochondrial Redox Homeostasis to Facilitate Obesity-Associated Breast Cancer Progression
    Dai, Jia-Zih
    Wang, Yen-Ju
    Chen, Cheng-Hsun
    Tsai, I-Lin
    Chao, Yi-Chun
    Lin, Cheng-Wei
    ADVANCED SCIENCE, 2022, 9 (12)
  • [29] BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis
    Chongbiao Huang
    Hui Li
    Yang Xu
    Chao Xu
    Huizhi Sun
    Zengxun Li
    Yi Ge
    Hongwei Wang
    Tiansuo Zhao
    Song Gao
    Xiuchao Wang
    Shengyu Yang
    Peiqing Sun
    Zhe Liu
    Jing Liu
    Antao Chang
    Jihui Hao
    Signal Transduction and Targeted Therapy, 8
  • [30] BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis
    Huang, Chongbiao
    Li, Hui
    Xu, Yang
    Xu, Chao
    Sun, Huizhi
    Li, Zengxun
    Ge, Yi
    Wang, Hongwei
    Zhao, Tiansuo
    Gao, Song
    Wang, Xiuchao
    Yang, Shengyu
    Sun, Peiqing
    Liu, Zhe
    Liu, Jing
    Chang, Antao
    Hao, Jihui
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)